arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Humacyte, Inc.

HUMA

$0.72 ▲ +0.02 (+2.36%) at close

26 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Humacyte, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $142.4M

Dividend Yield —

Revenue Growth -4.3%

Op. Margin —

ROIC -48.1% ↗

FCF / Share $-0.13

Trailing P/E —

Price / Book 13.8x

FCF Yield —

Debt / Equity 3.09

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$495.00K

↓ -4.3% —

Net Income Profit after all expenses

$-17.62M

↑ +29.0% —

FCF / Share Free cash flow per share

$-0.13

↑ +41.7% —

Long-Term Debt Long-term obligations

$35.87M

↑ +1.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-4.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-153%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-73.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1020%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	6.2% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	33.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-32.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-118.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	19.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-500.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	-89.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	65.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	94.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	76.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-18.5% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	16.6% Good ↑ Good Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	-574.9% Weak ↓ Weak Declining Year-over-year change in net income	-86.4% Weak → Weak Stable Year-over-year change in net income	-86.4% Weak ↓ Weak Declining Year-over-year change in net income	-86.4% Weak ↓ Weak Declining Year-over-year change in net income	N/M	2.3% Caution → Caution Stable Year-over-year change in net income	2.3% Caution ↑ Caution Improving Year-over-year change in net income	2.3% Caution Caution Year-over-year change in net income	N/M	-14.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	41.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	14.4% Fair Fair Year-over-year change in free cash flow	—	—	—	-33.7% Weak Weak Year-over-year change in free cash flow	—	—	—	-4.9% Weak Weak Year-over-year change in free cash flow	—	—	—	92.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	-3.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	1.43x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.74x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.27x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	5.28x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-48.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-63.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	405.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-579.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-50.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	42.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	82.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-80.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-152.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.0% Caution → Caution Stable Return earned on debt + equity capital invested Optimal: > 10%	4.3% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	3.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	4.1% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-26.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-14.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-151.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1110%)	—	—	—	108.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+624%)	39.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+165%)	50.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+234%)	112.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+652%)	-122.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-913%)	-185.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1336%)	-99.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-766%)	-60.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-503%)	-45.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-16.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-13.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-19.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	34.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+132%)	-26.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	5.3% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-64%)	5.6% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	4.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	5.3% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-65%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	3.09x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+414%)	11.40x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+1800%)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	0.21x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-52%)	—	0.26x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	-14.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-16.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.63x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.25x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-12.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.32x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-12.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.86x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-37.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-28.97x Weak Weak Operating income divided by interest expense Optimal: > 5x	-31.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-12.67M	$-15.05M	$-19.49M	$-38.03M	$-62.85M	$-44.94M	$-20.57M	$-93.56M	$-115.50M	$-80.45M	$-99.99M	$-114.60M	$-129.57M	$-149.77M	$-163.73M	$-151.03M	$-168.22M	$-217.50M	$-220.45M	—	—	$-39.93M	—	—	—	—
Debt / EBITDA (x)	-1.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	-1.76x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.48x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.01	—	—	—	$0.16	—	—	—
Basic EPS, GAAP (USD)	$-0.09	$-0.15	$-0.11	$-0.24	$0.28	$-0.16	$-0.33	$-0.48	$-0.29	$-0.24	$-0.25	$-0.22	$-0.36	$-0.04	$-0.25	$0.36	$-0.19	$3.03	$-0.72	$-2.89	$-3.46	$-2.80	$-3.07	—	—	—
Free Cash Flow per Share (USD)	$-0.13	—	$-0.15	$-0.17	$-0.22	—	—	—	$-0.26	—	—	—	$-0.19	—	—	—	$-0.18	—	—	$-2.48	$-2.48	—	—	—	—	—
Book Value per Share (USD)	$0.05	$0.02	$-0.03	$0.03	$0.23	$-0.41	$-0.53	$-0.24	$0.22	$0.13	$0.36	$0.59	$0.79	$1.13	$1.15	$1.38	$1.01	$1.19	$0.74	$-63.91	$-62.22	$-60.17	$-57.95	—	—	—
Tangible Book Value per Share (USD)	$0.05	$0.02	$-0.03	$0.03	$0.23	$-0.41	$-0.53	$-0.24	$0.22	$0.13	$0.36	$0.59	$0.79	$1.13	$1.15	$1.38	$1.01	$1.19	$0.74	$-63.91	$-62.22	$-60.17	$-57.95	—	—	—
Basic Weighted Avg Shares (shares)	197.85M	—	158.31M	155.44M	131.50M	—	119.41M	119.17M	108.25M	—	103.44M	103.36M	103.26M	—	103.03M	103.01M	103.00M	—	43.95M	5.94M	5.87M	—	5.79M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$47.41M	$49.42M	$15.77M	$30.64M	$53.68M	$27.91M	$2.06M	$78.35M	$103.84M	$64.83M	$87.71M	$109.17M	$110.25M	$134.63M	$156.71M	$181.97M	$198.53M	$218.29M	$222.93M	—	—	$30.22M	—	—	—	—
LT Debt (USD)	$35.87M	$35.44M	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	$30.00M	$30.00M	—	$20.00M	—	—	—	—	—	—	—
Total Equity (USD)	$11.62M	$3.11M	$-4.75M	$4.05M	$36.04M	$-52.67M	$-63.72M	$-28.29M	$26.15M	$13.55M	$36.99M	$61.12M	$81.89M	$116.93M	$118.67M	$142.26M	$103.89M	$122.17M	$75.86M	$-379.76M	$-365.52M	$-350.32M	$-335.40M	$-318.82M	$-305.11M	$-288.79M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$495.00K	$467.00K	$753.00K	$301.00K	$517.00K	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	$241.00K	—	—	—	$914.00K	—	—	—
Depreciation Expense (USD)	$1.34M	$1.34M	$1.30M	$1.30M	$1.31M	$1.28M	$1.30M	$1.30M	$1.27M	$1.32M	$1.30M	$1.50M	$1.56M	$1.60M	$1.50M	$1.50M	$1.52M	$1.53M	$1.50M	$1.60M	$1.55M	$1.56M	$1.60M	—	—	—
Net Income, GAAP (USD)	$-17.62M	$-24.80M	$39.14M	$39.14M	$39.14M	$-20.94M	$-31.90M	$-31.90M	$-31.90M	$-25.11M	$-36.97M	$-36.97M	$-36.97M	$-3.72M	$-19.83M	$-19.83M	$-19.83M	$42.59M	$-20.30M	$-20.30M	$-20.30M	$-16.21M	$-17.67M	—	—	—
Operating Cash Flow (USD)	$-25.10M	$-26.12M	$-23.90M	$-26.41M	$-28.60M	$-26.58M	—	—	$-27.35M	$-19.05M	—	—	$-18.64M	$-18.96M	—	—	$-18.80M	$-21.45M	—	$-14.68M	$-14.54M	$-15.20M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Humacyte, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HUMA with peers